financetom
Business
financetom
/
Business
/
Salesforce Insider Sold Shares Worth $3,637,398, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Salesforce Insider Sold Shares Worth $3,637,398, According to a Recent SEC Filing
Jun 11, 2024 12:30 AM

03:13 AM EDT, 06/11/2024 (MT Newswires) -- Marc Benioff, Director, Chair and Chief Executive Officer, on June 07, 2024, sold 15,000 shares in Salesforce ( CRM ) for $3,637,398. Following the Form 4 filing with the SEC, Benioff has control over a total of 22,317,327 shares of the company, with 12,210,327 shares held directly and 10,107,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1108524/000112760224018324/xslF345X03/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Nov 22, 2024
08:48 AM EST, 11/22/2024 (MT Newswires) -- Consumer stocks were edging higher premarket Friday as the Consumer Staples Select Sector SPDR Fund (XLP) was advancing 0.01% and the Consumer Discretionary Select Sector SPDR Fund (XLY) was flat recently. Tapestry (TPR) shares advanced by over 3% after the company announced accelerated share repurchase deals with Bank of America and Morgan Stanley...
Johnson & Johnson Applies for FDA Approval of Tremfya Subcutaneous Induction Regimen for Ulcerative Colitis
Johnson & Johnson Applies for FDA Approval of Tremfya Subcutaneous Induction Regimen for Ulcerative Colitis
Nov 22, 2024
08:47 AM EST, 11/22/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday it has applied to the US Food and Drug Administration seeking approval of a subcutaneous induction regimen of Tremfya to treat adults with moderately to severely active ulcerative colitis. The company said its supplemental biologics license application, or SBLA, is based on phase 3 study...
Calumet Says $354.4 Million Senior Notes Tendered in Exchange Offer
Calumet Says $354.4 Million Senior Notes Tendered in Exchange Offer
Nov 22, 2024
08:49 AM EST, 11/22/2024 (MT Newswires) -- Calumet (CLMT) said Friday that about $354.4 million of 11% senior notes due 2025 were validly tendered in its private exchange offer for newly issued 11% senior notes due 2026. The tendered amount represents about 97.5% of the outstanding old notes, according to the company. Settlement for the exchange offer, which expired Thursday,...
CIBC Comments on Canada's Retail Sales Data
CIBC Comments on Canada's Retail Sales Data
Nov 22, 2024
08:47 AM EST, 11/22/2024 (MT Newswires) -- Canadian retail sales look to be getting a boost from lower interest rates, as total sales rose by a healthy 0.4% month over month in September and the increase looked even better in volume terms, at 0.8%, said CIBC. Friday's headline was in line with consensus expectations, and gains were broad-based, with six...
Copyright 2023-2026 - www.financetom.com All Rights Reserved